Lung carcinoma continues to account for more cancer deaths than any other tumor due to lack of effective screening and early detection tests and to a propensity for early metastatic spread. During the coming funding period, the Colorado EDRN Biomarker Development Laboratory will continue the phased development of molecular biomarkers to: 1) detect prevalent lung carcinoma at an early stage; 2) identify premalignant lesions in high risk smokers that may be targeted for chemoprevention; and 3) develop biomarkers that predict incident lung carcinoma in high risk smokers initially without tumor. The Laboratory will build on past success using state-of-the art oligonucleotide microarray technology to discover molecular markers that are highly overexpressed in tumors but silent in normal tissue. So far the most promising of the markers identified this method are CTAG genes which represent a unique new family of biomarker molecules that are expressed exclusively by tumor cells and germ cells. To identify small numbers of heterogeneous tumor cells in clinical samples, panels of biomarkers will be assessed by multiplex RT-PCR, real time quantitative RT-PCR and protein immunoassays in a broad range of cell lines, tumors, normal tissues, peripheral blood, sputum and other surrogate markers. An underlying premise of the program is that unbalance gene expression derives from chromosomal instability. Chromosomal instability is reflected by aneusomy in malignant and premalignant epithelial cells. We plan to validate chromosomal instability/aneusomy by applying multiprobe FISH to the unique retrospective repository specimens from the Colorado High Risk Cohort and to compare predictive power of FISH with cytology and methylation of suppressor gone promoters in collaboration with Dr. Steve Belinsky. We expect that one or more of these biomarkers will be sufficiently promising that it may be applied to specimens currently being collected through the spiral CT project of ACRIN currently being housed in the Colorado repository.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA085070-09
Application #
7275348
Study Section
Special Emphasis Panel (ZCA1-SRRB-E (O1))
Program Officer
Krueger, Karl E
Project Start
1999-09-30
Project End
2009-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
9
Fiscal Year
2007
Total Cost
$418,024
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Rafnar, Thorunn; Sulem, Patrick; Besenbacher, Soren et al. (2011) Genome-wide significant association between a sequence variant at 15q15.2 and lung cancer risk. Cancer Res 71:1356-61
Varella-Garcia, Marileila; Schulte, Aline P; Wolf, Holly J et al. (2010) The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence. Cancer Prev Res (Phila) 3:447-53
Bellini, Marilanda F; Manzato, Antonio J; Silva, Ana E et al. (2010) Chromosomal imbalances are uncommon in chagasic megaesophagus. BMC Gastroenterol 10:20
Ostroff, Rachel M; Bigbee, William L; Franklin, Wilbur et al. (2010) Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One 5:e15003
Franklin, Wilbur A; Haney, Jerry; Sugita, Michio et al. (2010) KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer. J Mol Diagn 12:43-50
Massion, Pierre P; Zou, Yong; Uner, Hasmet et al. (2009) Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer. PLoS One 4:e5611
Weiss, G J; Bemis, L T; Nakajima, E et al. (2008) EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann Oncol 19:1053-9
Jonsson, Steinn; Varella-Garcia, Marileila; Miller, York E et al. (2008) Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancer. Am J Respir Crit Care Med 177:342-7
Bemis, Lynne T; Robinson, William A; McFarlane, Robert et al. (2007) EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome. Lancet Oncol 8:559-60
Varella-Garcia, Marileila; Chen, Lin; Powell, Roger L et al. (2007) Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer. Am J Respir Crit Care Med 176:505-12

Showing the most recent 10 out of 28 publications